Mitsubishi Corporation to Expand its Product Portfolio for Medical Institutions
June 19, 2013     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Mitsubishi Corporation to Expand its Product Portfolio for Medical Institutions - JCN Newswire
Share:
Mitsubishi Corporation to Expand its Product Portfolio for Medical Institutions
 
Acquiring 80% of Kobayashi Medical, Kobayashi Pharmaceutical's Medical Device Import and Distribution Company

Tokyo, Apr 24, 2012 - (JCN Newswire) - Mitsubishi Corporation ("MC") will strengthen its medical device import and distribution business by expanding its product offerings for medical institutions. As part of this strategy, Mitsubishi Corporation has agreed today with Kobayashi Pharmaceutical to acquire 80% of Kobayashi Medical, a wholly-owned subsidiary of Kobayashi Pharmaceutical.

With the aging of society, companies involved in the medical field are increasingly seeking to offer safe medical devices to treat lifestyle diseases such as cancer as well as myocardial infarction, strokes, and bone fractures.

MC is involved in the import and distribution of medical devices through its group company, which mainly handles endoscopes and surgical instruments in minimally invasive surgery and urology.

Teaming up with Kobayashi Medical, which handles bone fracture treatment equipment and surgical instruments, will enable MC to offer a wider range of devices and products. In addition, MC is aiming to expand Kobayashi Medical's business by leveraging MC's global network and partnerships with its group companies.

Through the medical field business, Mitsubishi Corporation is working to create sustainable corporate value by contributing to economic and social development.

1. Summary of Kobayashi Medical
(1) Headquarters: 2-5-8 Imabashi, Chuo-ku, Osaka City, Osaka
(2) Establishment: April, 2010
(3) Capital: 50 mil. JPY (As of March 31, 2011)
(4) Business: Import and distribution of medical devices
(5) Employees: 243 (As of March 31, 2011)
(6) Principal Shareholders: 100% Kobayashi Pharmaceutical
(7) Representative: President & CEO Hiroshi Kudo

2. Summary of Kobayashi Pharmaceutical
(1) Headquarters: 4-4-10 Doshomachi, Chuo-ku, Osaka City, Osaka
(2) Establishment: August, 1919
(3) Capital: 3,450 mil. JPY (As of March 31, 2011)
(4) Business: Manufacture and sales of pharmaceuticals, non-pharmaceuticals, deodorizers and sanitary supplies
(5) Revenue: 130.8 bil. JPY (As of 31, March, 2011)
(6) Employees: Consolidated 2.390/ Non-consolidated 1,040 (As of March 31, 2011)
(7) Representative: President & CEO Yutaka Kobayashi

3.Summary of Mitsubishi Corporation
(1) Headquarters: 3-1, Marunouchi 2-Chome, Chiyoda-ku, Tokyo, 100-8086, Japan
(2) Establishment: July 1, 1954
(3) Capital: 203,598 mil JPY (As of March 31, 2011)
(4) Business: Mitsubishi Corporation (MC) has six Business Groups which develop operations in the diverse fields of Industrial Finance, Logistics & Development, Energy, Metals, Machinery, Chemicals, and Living Essentials. In addition to these Business Groups, MC has also established the Business Service Group and Global Environment Business Development Group.
(5) Sales: 19,233 bil. JPY
(6) Employees: 58,470 (as of March 31, 2011)
(7) Representative: Ken Kobayashi, President and Chief Executive Officer

About Mitsubishi Corporation

Mitsubishi Corporation (MC; TSE: 8058) is a global integrated business enterprise that develops and operates businesses across virtually every industry including industrial finance, energy, metals, machinery, chemicals, foods, and environmental business. MC's current activities are expanding far beyond its traditional trading operations as its diverse business ranges from natural resources development to investment in retail business, infrastructure, financial products and manufacturing of industrial goods. With over 200 bases of operations in approximately 80 countries worldwide and a network of over 500 group companies, MC employs a multinational workforce of nearly 60,000 people. For more information, please visit www.mitsubishicorp.com.

Contact:

Mitsubishi Corporation
Telephone:+81-3-3210-2171
Facsimile:+81-3-5252-7705

 


Apr 24, 2012
Source: Mitsubishi Corporation

Mitsubishi Corporation (TSE: 8058) (FTSE: MBC)

From the Japan Corporate News Network
http://www.japancorp.net
Topic: Merger & Acquisition
View more news from these Sectors: Trade General


 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)